Immediate Impact

1 by Nobel laureates 5 from Science/Nature 66 standout
Sub-graph 1 of 24

Citing Papers

Myelodysplastic Syndromes
2020 Standout
Epigenetic Therapies for Cancer
2020 Standout
4 intermediate papers

Works of F Beeldens being referenced

Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
2011

Author Peers

Author Last Decade Papers Cites
F Beeldens 519 148 294 11 634
Andreas Grüneisen 426 150 211 11 581
Mette Skov Holm 444 126 270 19 611
Mohammad Azab 295 67 360 19 517
J. Bickers 495 203 282 12 664
A. Kuendgen 563 90 228 22 678
Shama L. van Zelderen‐Bhola 432 172 194 10 676
Leandro de Pádua Silva 562 192 222 25 730
J O Moore 430 168 145 9 593
Mary‐Frances McMullin 591 227 315 10 681
Kathleen Dugan 308 86 249 11 648

All Works

Loading papers...

Rankless by CCL
2026